Filing Details
- Accession Number:
- 0001493152-25-001298
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-01-08 06:10:48
- Reporting Period:
- 2025-01-06
- Accepted Time:
- 2025-01-08 06:10:48
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1799788 | Greenwich Lifesciences Inc. | GLSI | Pharmaceutical Preparations (2834) | 205473709 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1806920 | Snehal Patel | C/O Greenwich Lifesciences, Inc. 3992 Bluebonnet Dr., Building 14 Stafford TX 77477 | Ceo And Cfo | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2025-01-06 | 1,100 | $13.31 | 5,548,202 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2025-01-07 | 1,800 | $13.75 | 5,550,002 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |